These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7997065)

  • 1. Interaction between psychological and pharmacological treatment in cognitive impairment.
    Deberdt W
    Life Sci; 1994; 55(25-26):2057-66. PubMed ID: 7997065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of piracetam in treating information processing, reading and writing disorders in dyslexic children.
    Tallal P; Chase C; Russell G; Schmitt RL
    Int J Psychophysiol; 1986 May; 4(1):41-52. PubMed ID: 3522509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piracetam and dyslexia: effects on reading tests.
    Wilsher CR; Bennett D; Chase CH; Conners CK; DiIanni M; Feagans L; Hanvik LJ; Helfgott E; Koplewicz H; Overby P
    J Clin Psychopharmacol; 1987 Aug; 7(4):230-7. PubMed ID: 3305591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence.
    Kampman K; Majewska MD; Tourian K; Dackis C; Cornish J; Poole S; O'Brien C
    Addict Behav; 2003 Apr; 28(3):437-48. PubMed ID: 12628617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of piracetam in children with dyslexia.
    Di Ianni M; Wilsher CR; Blank MS; Conners CK; Chase CH; Funkenstein HH; Helfgott E; Holmes JM; Lougee L; Maletta GJ
    J Clin Psychopharmacol; 1985 Oct; 5(5):272-8. PubMed ID: 3900148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
    Kessler J; Thiel A; Karbe H; Heiss WD
    Stroke; 2000 Sep; 31(9):2112-6. PubMed ID: 10978039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.
    Amieva H; Meillon C; Helmer C; Barberger-Gateau P; Dartigues JF
    PLoS One; 2013; 8(1):e52755. PubMed ID: 23326356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders.
    Vernon MW; Sorkin EM
    Drugs Aging; 1991 Jan; 1(1):17-35. PubMed ID: 1794001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Fast" and "slow" components of psychotropic activity of the drugs with nootropic effects].
    Neznamov GG; Siuniakov SA; Davydova IA; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(6):33-7. PubMed ID: 10900686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of piracetam in the treatment of acute and chronic aphasia.
    Huber W
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():38-43. PubMed ID: 10338107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.
    Huber W; Willmes K; Poeck K; Van Vleymen B; Deberdt W
    Arch Phys Med Rehabil; 1997 Mar; 78(3):245-50. PubMed ID: 9084344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial of piracetam in two subgroups of students with dyslexia enrolled in summer tutoring.
    Ackerman PT; Dykman RA; Holloway C; Paal NP; Gocio MY
    J Learn Disabil; 1991 Nov; 24(9):542-9. PubMed ID: 1765729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piracetam therapy does not enhance cognitive functioning in children with down syndrome.
    Lobaugh NJ; Karaskov V; Rombough V; Rovet J; Bryson S; Greenbaum R; Haslam RH; Koren G
    Arch Pediatr Adolesc Med; 2001 Apr; 155(4):442-8. PubMed ID: 11296070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute nootropic effects of Ginkgo biloba in healthy older human subjects: a preliminary investigation.
    Nathan PJ; Ricketts E; Wesnes K; Mrazek L; Greville W; Stough C
    Hum Psychopharmacol; 2002 Jan; 17(1):45-9. PubMed ID: 12404706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
    Enderby P; Broeckx J; Hospers W; Schildermans F; Deberdt W
    Clin Neuropharmacol; 1994 Aug; 17(4):320-31. PubMed ID: 9316679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Brain-specific" nutrients: a memory cure?
    McDaniel MA; Maier SF; Einstein GO
    Nutrition; 2003; 19(11-12):957-75. PubMed ID: 14624946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
    Güngör L; Terzi M; Onar MK
    Brain Lang; 2011 Apr; 117(1):23-7. PubMed ID: 21227483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of piracetam on short- and long-term verbal retrieval in dyslexic boys.
    Helfgott E; Rudel RG; Kairam R
    Int J Psychophysiol; 1986 May; 4(1):53-61. PubMed ID: 3522510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piracetam as an aid to learning in dyslexia. Preliminary report.
    Wilsher C; Atkins G; Manfield P
    Psychopharmacology (Berl); 1979 Sep; 65(1):107-9. PubMed ID: 116285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piracetam--an old drug with novel properties?
    Winnicka K; Tomasiak M; Bielawska A
    Acta Pol Pharm; 2005; 62(5):405-9. PubMed ID: 16459490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.